Lung damage after COVID: how do patients heal?

NCT ID NCT04505631

Completed Knowledge-focused Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study followed 332 adults who were hospitalized with severe COVID-19 pneumonia and needed oxygen. Researchers used CT scans and breathing tests to check for lasting lung damage. The goal was to understand how the lungs recover after a serious infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 Dyspnea lung disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID19 DYSPNEA

Contacts and locations

Locations

Centre Hospitalier Annecy Genevois

Metz-Tessy, France
Centre Hospitalier Colmar

Colmar, France
Centre Hospitalier Douai

Douai, France
Centre Hospitalier Départemental Vendée - La Roche sur Yon

La Roche-sur-Yon, France
Centre Hospitalier Le Raincy Montfermeil

Montfermeil, France
Centre Hospitalier Métropole Savoie

Chambéry, France
Centre Hospitalier Robert Boulin - Libourne

Libourne, France
Centre Hospitalier Régional Metz-Thioville

Metz, France
Centre Hospitalier Régional Orléans

Orléans, France
Centre Hospitalier de Dunkerque

Dunkirk, France
Centre Hospitalier de Soissons

Soissons, France
Centre Hospitalier de la Côte Basque - Bayonne

Bayonne, France
Centre Hospitalier du Mans

Le Mans, France
Groupe Hospitalier de Mulhouse et de la Région Sud-Alsace

Mulhouse, Alsace, 68100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.